Suggestions
Samir Khan
Health Innovation Catalyst - Market Access & Pricing Expert - Global Impact-maker
Samir Khan is a distinguished health innovation strategist and global market access professional with over eight years of experience in the Life Sciences and Healthcare sector.
He is known for his expertise in developing user-centric design, evidence-based, and commercial access solutions for public and corporate leaders investing in areas such as preventative and precision medicine, diagnostics, AI, digital therapeutics, and system transformation.
Samir has served as a strategic access advisor to investors, top global Life Sciences and Healthcare businesses, NHS England, and numerous start-ups, offering guidance on international market access strategies, payer engagement, value-based pricing, and risk-sharing agreements across various healthcare fields including oncology, rare diseases, mental health, and chronic inflammatory indications.
His notable achievements include being a Panel Reviewer for the NHSX-NIHR's AI Award in 2020 (£250 million) and holding strategic advisory roles at renowned organizations like Jiva.ai, Oxford Immune Algorithmics, Aya Technologies, and Unbounded Future.
In terms of education, Samir holds an MSc in Biochemistry (2.1) from the Department of Biochemistry at Aligarh University, a Doctor of Philosophy in Molecular Pharmacology from the University of Cambridge under the Bill and Melinda Gates Trust Scholarship, and a BSc Honors in Biochemistry (2.1) from Aligarh University.
Throughout his career, Samir Khan has been associated with various organizations in key roles such as Co-Founder & CEO at Lighthouse Innovations Ltd, Programme Advisor for Market Access & Pricing at TheHill, Start-up Mentor at P4 Precision Medicine Accelerator, Global Access & Pricing Advisor at KQ Labs, and Business Strategy & Market Access Manager at Oxford Academic Health Science Network (Oxford AHSN).
He has also contributed his expertise as a Consultant in Market Access and Healthcare at Ipsos, Global Market Access Consultant at GfK, Operations and Commercial Strategy at New Medicine Partners, Senior Analyst at Xyntéo, Associate Consultant focusing on Market Access Strategy & Commercial Effectiveness at Pope Woodhead & Associates Ltd, Medicines & Analytics Intern at The Centre for Sustainable Healthcare, Business Development Consultant at Healx3, Associate Director at Ekstasy, and Industrial Post-Doctoral Research Scientist at Heptares.
Samir Khan's academic journey includes serving as President at Darwin College, Cambridge, a PhD Scholar under the Bill & Melinda Gates fellowship in Pharmacology at the University of Cambridge, and as a Junior Research Fellow at ICGEB.